Výsledky vyhledávání - "J J, Pérez Venegas"

AB1030 PATIENT CARE AT THE FRACTURE LIAISON SERVICE REDUCE THE GAP IN THE TREATMENT OF OSTEOPOROSIS BETWEEN MEN AND WOMEN

Autor: B. Hernández-Cruz, M. J. Miranda García, J. Barrera, F. J. Olmo Montes, M. A. Vázquez Gómez, M. Giner García, M. A. Colmenero Camacho, J. J. Pérez Venegas, M. J. Montoya García

Publikováno v: Annals of the Rheumatic Diseases. 81:1638-1639

BackgroundOsteoporosis (OP) between men and women is different,and the way it is treated also differs. In men, the gap in clinical care, especially diagnosis and treatment, is worse.ObjectivesTo analyze the differences in the clinical characteristics

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d0ff7096eeffc71e46fc3f313b2dd725
https://doi.org/10.1136/annrheumdis-2022-eular.4150

Zobrazit plný text záznamu

AB1315 SARILUMAB IN PATIENTS WITH REFRACTORY GRAVES’ ORBITOPATHY. EFFECTIVENESS AND SAFETY IN A SERIES OF CASES IN CLINICAL PRACTICE

Autor: V. Moreira Navarrete, F. J. Toyos Sáenz de Miera, A. M. Garrido Hermosilla, P. Muñoz Reinoso, M. J. Madrigal Domínguez, J. J. Pérez Venegas

Publikováno v: Annals of the Rheumatic Diseases. 81:1764.2-1765

BackgroundGraves’ orbitopathy (GO) is an autoimmune disease of the retroocular tissues that occurs in patients with Graves’ disease. Tocilizumab (TCZ), an interleukin (IL)-6 inhibitor has been used in patients with glucocorticoid (GC)-resistant G

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d4fc04fdbcc1786adaf24ee371386555
https://doi.org/10.1136/annrheumdis-2022-eular.4039

Zobrazit plný text záznamu

AB0373 ABATACEPT IN MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL DISEASE-MODIFYING DRUGS: TREATMENT PERSISTENCE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS

Autor: P. Muñoz Reinoso, I. García Hernández, B. Hernández-Cruz, J. J. Pérez Venegas

Publikováno v: Annals of the Rheumatic Diseases. 81:1313.2-1314

BackgroundAbatacept is a selective T-cell co-stimulation modulator indicated for the treatment of moderate to severe active rheumatoid arthritis in patients with inadequate response to previous treatment. It is used in routine clinical practice in co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3efc1d450f43731cd5495bb08d2b9541
https://doi.org/10.1136/annrheumdis-2022-eular.4689

Zobrazit plný text záznamu

AB1404 ELECTRONIC CONSULTATION: A USEFUL TOOL TO OPTIMIZE THE ON-SITE MEDICAL CONSULTATION IN RHEUMATOLOGY

Autor: D. V. Mendoza Mendoza, D. Ruiz-Montesinos, V. Moreira Navarrete, J. J. Pérez Venegas

Publikováno v: Annals of the Rheumatic Diseases. 81:1807.3-1808

BackgroundElectronic consultation (e-Consults) is a form of telemedicine. It permits communication between primary health care (PHC) and hospital care (HC). It is proving to be a helpful tool to reduce waiting times in consultations, to prioritize th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e9c66c4e0fe47fba90252c4c5f558339
https://doi.org/10.1136/annrheumdis-2022-eular.3108

Zobrazit plný text záznamu

POS0376 THE ROLE OF ELECTRONIC CONSULTATION IN THE EARLY DIAGNOSIS OF INFLAMMATORY ARTHROPATHIES IN A THIRD LEVEL HOSPITAL

Autor: D. V. Mendoza Mendoza, D. Ruiz-Montesinos, V. Moreira Navarrete, J. J. Pérez Venegas

Publikováno v: Annals of the Rheumatic Diseases. 81:442.2-443

BackgroundThe relevance of early diagnosis in rheumatic inflammatory diseases is well known. Electronic consultation (e-Consults) is a tool for communication between primary health care (PHC) and hospital care (HC) physicians in order to present the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e28169ffaa7ba67edcd1fcfce99f43a7
https://doi.org/10.1136/annrheumdis-2022-eular.3066

Zobrazit plný text záznamu

AB0239 PERSISTENCE TO BIOLOGICAL DMARDS TNF INHIBITORS VS BIOLOGICAL DMARDS NO TNF INHIBITORS AFTER FAILURE TO SYNTHETIC CONVENTIONAL DMARDS IN RA PATIENTS TREATED IN STANDARD CLINICAL PRACTICE

Autor: J. J. Pérez Venegas, Dolores Ruiz-Montesinos, G. Jurado Quijano, I. García Hernández, A. Fernández Reboul Fernández, L. Fernández de la Fuente Bursón, I. M. Fernández-Maeztu Palacín, P. Muñoz Reinoso, Blanca Hernández-Cruz

Publikováno v: Annals of the Rheumatic Diseases. 80:1145.1-1145

Background:There are no RA response predictors for our patients. The decision to initiate a first biological depends on multiple factors such as rheumatologist experience, clinical characteristics of the patient and health system. What is clear is th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86a686ea6b7a24393249edcdbcfe3ed6
https://doi.org/10.1136/annrheumdis-2021-eular.3920

Zobrazit plný text záznamu

AB0612 THE FRACTURE PREVENTION UNIT OF THE VIRGEN MACARENA HOSPITAL REDUCES THE GAP IN THE MANAGEMENT OF OP, PARTICULARLY IN MALES AND MEETS IOF/ESCEO QUALITY STANDARDS

Autor: F. J. Olmo Montes, M. A. Colmenero Camacho, J. J. Pérez Venegas, M. García, Blanca Hernández-Cruz, M. J. Miranda García, M. D. Jimenez Moreno, M. A. Vázquez Gómez, M. Giner García

Publikováno v: Annals of the Rheumatic Diseases. 80:1341.2-1341

Background:The Virgen Macarena University Hospital belongs to the Public Health System of Andalusia and serves 481,296 inhabitants in Seville, Spain. In 2018 the Fracture Liaison Service switched to a multidisciplinary unit.Objectives:To describe FLS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2ba6534dd8a017c8a6593e4d6f34884d
https://doi.org/10.1136/annrheumdis-2021-eular.1448

Zobrazit plný text záznamu

AB0092 ANTISYNTHETASE SYNDROME: CLINICAL PROFILE, SEROLOGIC AND TREATMENTS USED IN A COHORT OF PATIENTS FOLLOWED AT THE VIRGEN MACARENA HOSPITAL

Autor: M. Ferrer Galván, I. García Hernández, L. Fernández de la Fuente Bursón, J. J. Pérez Venegas, F. J. Toyos Sáenz de Miera, P. Muñoz Reinoso

Publikováno v: Annals of the Rheumatic Diseases. 80:1075.1-1075

Background:The antisynthetase syndrome (SAS) is characterized by the presence of antisynthetase antibodies, anti-JO1, PL7 y PL12 are the most common; and the classic triad of myositis, arthritis, and diffuse interstitial lung disease (ILD)1. Most pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b36c037e39c68be70336b432470c07a7
https://doi.org/10.1136/annrheumdis-2021-eular.1427

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání